| 000 | 01507 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518001042.0 | ||
| 264 | 0 | _c20190103 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2018.08.065 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaraei, Raedeh | |
| 245 | 0 | 0 |
_aThe role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cNov 2018 |
||
| 300 |
_a1010-1019 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aTNF-Related Apoptosis-Inducing Ligand _xadministration & dosage |
| 650 | 0 | 4 |
_aX-Linked Inhibitor of Apoptosis Protein _xantagonists & inhibitors |
| 700 | 1 | _aSoleimani, Masoud | |
| 700 | 1 | _aMovassaghpour Akbari, Ali Akbar | |
| 700 | 1 | _aFarshdousti Hagh, Majid | |
| 700 | 1 | _aHassanzadeh, Ali | |
| 700 | 1 | _aSolali, Saeed | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 107 _gp. 1010-1019 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2018.08.065 _zAvailable from publisher's website |
| 999 |
_c28876475 _d28876475 |
||